Gland Pharma Ltd. ( (IN:GLAND) ) has issued an update.
Gland Pharma Limited has announced the closure of its trading window from March 29, 2025, until 48 hours after the declaration of its audited financial results for the quarter and financial year ending March 31, 2025. This move is in compliance with SEBI regulations to prevent insider trading, and the date for the board meeting to approve the financial results will be announced later.
More about Gland Pharma Ltd.
Gland Pharma Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of complex injectables. The company is known for its range of products that cater to various therapeutic areas and its emphasis on quality and compliance in the global market.
YTD Price Performance: -11.19%
Average Trading Volume: 10,244
Current Market Cap: 264.8B INR
Learn more about GLAND stock on TipRanks’ Stock Analysis page.